Håper det snart blir mer lys hos de som har det som mørkest rundt seg i verden nå. God jul! 🌟

Pathway is hosting a dedicated online seminar to discuss recent research. This is a good opportunity to delve into our work and interact with the research team. 📅 Date: Thursday Jan 25 ⏰ Time: 10 AM - 11:30 AM Teams link and program: see information in the picture.

The research team is in Oulu, presenting two pivotal studies on precise modeling of patient pathways, focusing on MS and kidney cancer, at the Nordic Conference on Digital Health and Wireless Solutions. link.springer.com/chapter/10.100… #DigitalHealth #patientpathways #cjml

Vi må finne frem til aksjonsformer mot ødeleggende prosjekter som Helseplattformen og "Nye OUS" som skaper krise for den helsebyråkratiske eliten, men minst mulig vansker for pasientene. Jeg katalyserer gjerne kontakt mellom relevante grupper og personer. tidsskriftet.no/2024/05/debatt…

Great collaboration! Well done Rosa Cortese

Letter from Pernilla Stridh MultipleMS Karolinska Institutet: Genotype differences might need time to manifest clinically in #MultipleSclerosis, and lack of associations likely reflects insufficient power. 🔽 journals.sagepub.com/doi/10.1177/13…

Our 3rd clinical series for 2024 is live: Multiple Sclerosis 2024. It covers advances in MS across 4 key areas: epidemiological trends, MRI for disease management, fluid biomarkers, & the impact of SARS-CoV-2 on MS. Explore these insights here👇 thelancet.com/series/multipl…

COVID-19 and multiple sclerosis: challenges and lessons for patient care - The Lancet Regional Health – Europe thelancet.com/journals/lanep…

New report Brain health – time matters in #MS, #NMOSD & #MOGAD launches 19 Sept 2024, 13:30–15:00 CET at ECTRIMS, in #Copenhagen & virtually. Join @GavinGiovannoni, Helmut Butzkeuven, Anne Helme, @NerdyNeuroMD & The Sumaira Foundation to learn about policy change. #BrainHealthTM #OHPF

Viktig debatt på riktige premisser! e-avis.aftenposten.no/shared/article…

The new ‘Brain health – time matters’ is now available to access. MSIF and its member organisations are proud to be involved with this important research, exploring the latest advancements and needs in MS, NMOSD, and MOGAD. Learn more here: msintfederation.org/3YCd6I8

The influence of menopause on multiple sclerosis - Simonsen - European Journal of Neurology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/en…

The "Brain Health – Time Matters" report highlights advancements in #MS, #NMOSD & #MOGAD, stressing early diagnosis & treatment. It calls for policy changes to support patients and includes rare neuroimmune conditions to improve global care. msbrainhealth.org

Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort st… pubmed.ncbi.nlm.nih.gov/39957514/

Thank you ECTRIMS and ACTRIMS® for your support and retweets! If anyone else cld repost this - in hopes of reaching as many women MS researchers as possible - that wld be v appreciated. MS Canada

Women with #MultipleSclerosis have reduced rates of childbirth compared with controls, from 3 years before onset. Population-based cohort study from Vestre Viken Elisabeth G. Celius ▶️ journals.sagepub.com/doi/full/10.11…

Original Article: Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis (HERCULES phase 3 trial) nej.md/4l3N9e5 #AANAM | American Academy of Neurology

Brain age in multiple sclerosis: a study with deep learning and traditional machine learning academic.oup.com/braincomms/art…

Skattebøl et al. report that deep learning predicts brain age in MS more accurately than traditional ML and resists scanner variability. Please read at: buff.ly/CqHOEG6 #MS

MAPLE is out-an important study of pharmacovigilance data by ⁦Merck Deutschland⁩ on the Safety of drug exposure of cladribine 6 months before or during🤰 . Only one MCA(1,1%) since data collection started in 2017. Very happy to see this paper online🥳. pubmed.ncbi.nlm.nih.gov/40587835/